What Does Less Than 50% Stenosis in Carotid Artery Mean?

Less than 50% stenosis in a carotid artery means the vessel supplying blood to your brain is mildly narrowed, with plaque blocking less than half of the artery’s internal diameter. Doctors generally classify this as “low-grade” or “mild” stenosis, and it almost never calls for surgery or stenting. Instead, you’ll typically be managed with medications and lifestyle changes. But mild narrowing is far more common than severe narrowing, and recent research has complicated the old assumption that a low percentage always equals low risk.

How the Number Is Measured

The percentage you see on your report comes from comparing the narrowest point inside the artery to a reference measurement of the normal vessel nearby. The most common first test is a carotid duplex ultrasound, a painless scan that uses sound waves to estimate blood-flow speed and vessel width. When ultrasound flags something, your doctor may order a CT angiography (CTA) scan for a sharper picture. In one hospital-based comparison, ultrasound correctly identified less-than-50% stenosis about 91% of the time when CTA was used as the reference standard. Agreement dropped for moderate stenosis in the 50–69% range, where nearly half of patients showed a different grade on ultrasound than on CTA.¹ An earlier study found that CTA correlated more closely with the traditional “gold standard” catheter angiogram than ultrasound did.²

What this means for you is practical: if your ultrasound report says “less than 50%,” the reading is very likely correct for that category. The measurement becomes less reliable once narrowing approaches the borderline between mild and moderate. If your doctor is uncertain or the number sits close to 50%, a CTA or MR angiogram can settle the question.

How Risky Is Mild Stenosis, Really?

For people with no symptoms, a carotid artery narrowed by less than 50% carries a relatively low annual risk of stroke on the same side. One long-term follow-up study found an annual event rate of roughly 2% each for stroke and transient ischemic attack (TIA) ipsilateral to the stenosis.³ A separate study comparing people with mild versus moderate asymptomatic stenosis over an average of nearly five years found no significant difference in stroke rates, heart attacks, or death between the two groups.⁴ That second finding is worth emphasizing: having moderate stenosis didn’t clearly raise the danger compared with mild stenosis, at least within the follow-up window studied.

For people who have already had a stroke or TIA, the calculus changes. A systematic review and meta-analysis looking at non-stenotic carotid plaques (those causing less than 50% narrowing) reported that the risk of a recurrent stroke or TIA on the same side was about 2.6 per 100 person-years, rising to 4.9 per 100 person-years when intraplaque hemorrhage was present.⁵ The recurrent-event rate is noticeably higher than the first-ever event rate of about 0.5 per 100 person-years found in the same review. So the distinction between “never had symptoms” and “already had an event” matters enormously, even when the degree of narrowing is the same.

Why the Percentage Doesn’t Tell the Whole Story

Traditional guidelines draw treatment lines based on how tight the narrowing is. But a growing body of research suggests that what the plaque is made of, and how unstable it is, may matter as much as the percentage. Two features in particular have attracted attention: intraplaque hemorrhage (bleeding inside the plaque) and plaque ulceration (a break in the plaque’s surface cap).

Counterintuitively, plaques causing only mild stenosis can carry more of these dangerous features than plaques causing severe narrowing. A histological study found that plaques from symptomatic patients with mild stenosis had a significantly higher proportion of intraplaque hemorrhage compared with those from patients with moderate or severe stenosis.⁶ A separate retrospective cohort study reinforced that finding: patients with symptomatic mild-to-moderate stenosis had roughly five times the odds of harboring vulnerable plaque features compared with patients who had high-grade stenosis without symptoms, and about seven and a half times the odds compared with high-grade symptomatic patients.⁷ MRI-based research from the PARISK study found that intraplaque hemorrhage was itself independently associated with disrupted plaque surfaces after adjusting for factors like age, sex, diabetes, and degree of stenosis.⁸

The implication is important: a “less than 50%” reading on your report is reassuring in terms of blood-flow obstruction, but it does not automatically mean the plaque sitting there is harmless. Clinicians are increasingly looking beyond the percentage at plaque composition, especially when a patient has had neurological symptoms that could point to a carotid source.

Non-Stenotic Plaques and “Cryptogenic” Stroke

A substantial share of strokes land in a frustrating diagnostic category: the workup rules out atrial fibrillation, severe carotid disease, and other common causes, yet the stroke clearly happened. These events are sometimes labeled “embolic stroke of undetermined source.” Researchers have increasingly turned their attention to carotid plaques that fall below the 50% stenosis threshold as a possible culprit in these cases.

A meta-analysis pooling data from over 18,000 stroke and TIA patients found that about half had non-stenotic carotid plaques, and the prevalence was roughly the same whether the analysis included all patients or only those with embolic stroke of undetermined source.⁹ Another systematic review found that among patients with embolic stroke of undetermined source, about a third of ipsilateral carotid arteries showed mild stenosis with high-risk plaque features, and the odds of finding such features on the same side as the stroke were more than five times higher than on the opposite side.¹⁰ A multimodality review in the American Journal of Neuroradiology argued that symptomatic non-stenotic carotid disease is being recognized more often as a thromboembolic source in patients who would otherwise be filed under “cause unknown.”¹¹

This is an area where clinical practice is actively shifting. If you have had a stroke that nobody can explain and your carotid ultrasound shows “less than 50%” stenosis, your neurologist may still want advanced imaging of the plaque itself to see whether it has features that could have sent a clot to your brain.

Will Mild Stenosis Get Worse Over Time?

Plaque can grow. The relevant question is how fast and how often mild stenosis progresses to something more serious. A study of patients with ischemic stroke who had mild-to-moderate stenosis found that arteries already above 50% were at higher risk of progressing further, while those below 50% progressed less often.¹² A long-term follow-up study of asymptomatic patients found that stenosis progressed in roughly two-thirds of vessels over many years, but progression of stenosis itself did not independently predict who would go on to develop symptoms after accounting for other risk factors like baseline stenosis severity, plaque ulceration, and intracranial disease.¹³

Among modifiable factors linked to plaque progression, plaque thickness itself was the strongest independent predictor in one large substudy, while age, male sex, smoking, and coronary heart disease were all more common in patients whose plaque grew.¹⁴ The practical takeaway: mild stenosis does not always stay mild, but it usually progresses slowly, and the factors that push it forward are largely the same cardiovascular risk factors your doctor is already trying to control.

How Mild Stenosis Is Treated

Surgery and stenting are not recommended for less-than-50% stenosis. Both the European Society of Vascular Surgery and the Society for Vascular Surgery are clear on this: in symptomatic patients with less than 50% stenosis and asymptomatic patients with less than 60% stenosis, optimal medical therapy alone is the standard of care.¹⁵ ¹⁶ “Optimal medical therapy” is a clinical shorthand that boils down to a few pillars.

Statins are central to the strategy, and their benefit extends beyond simply lowering cholesterol. An MRI-based study showed that increasing statin dose produced a measurable reduction in carotid plaque volume of nearly 9% over six months, while patients who stayed on their existing dose showed no significant change.¹⁷ A randomized trial comparing different statin-based lipid-lowering strategies found that combining statins with additional lipid-lowering agents achieved the greatest plaque regression over twelve months.¹⁸

Antiplatelet therapy is more nuanced at this level of stenosis. European guidelines suggest long-term low-dose aspirin for asymptomatic patients with more than 50% stenosis to reduce cardiovascular events broadly, but the benefit is less certain for moderate stenosis in the 50–75% range and is not specifically recommended for those below 50%.¹⁹ A meta-analysis of aspirin in asymptomatic carotid atherosclerosis found no significant reduction in major vascular events or death compared with control groups, though a subset analysis showed aspirin did slow thickening of the artery wall when compared with placebo alone.²⁰ If you’ve already had a stroke or TIA, your doctor will likely prescribe an antiplatelet regardless of the stenosis percentage, because the proven benefit in secondary stroke prevention comes from the event history, not the degree of narrowing.

What You Can Do Beyond Medication

Blood pressure control appears to be the single most impactful modifiable factor for actual plaque regression. A two-year dietary intervention trial found that weight loss was associated with plaque regression across low-fat, Mediterranean, and low-carbohydrate diets alike, but when all the variables were sorted out, the decline in systolic blood pressure was the only independent predictor of both plaque volume and artery-wall-thickness regression.²¹ That is worth remembering: the specific diet you follow matters less than whether it helps you lose weight and lower your blood pressure.

Structured lifestyle programs, however, do not always shrink plaque within the time frames studied. One comparative analysis found that neither an intensive community health program nor a standard healthy-heart program produced plaque regression in patients with established coronary artery disease after nine months, though both improved risk factors like cholesterol and blood pressure.²² So improving your risk profile is realistic on a shorter timeline; measurable plaque shrinkage takes longer and usually requires medication as well.

How Often You Need Follow-Up Imaging

Not every mild stenosis needs the same surveillance schedule. A single-institution analysis of progression rates recommended that patients with 0–39% stenosis return for a follow-up ultrasound at six-year intervals, while patients with 40–59% stenosis should be checked annually to catch anyone progressing toward a level that might warrant intervention.²³ Your own doctor may adjust these intervals based on your symptoms, risk factors, and whether you’re tolerating your medications well. But the general principle is that very mild narrowing can be watched infrequently, while narrowing closer to the 50% boundary deserves closer attention.

Sex Differences in Plaque Danger

Men and women with the same percentage of stenosis don’t necessarily carry the same risk profile. MRI studies of patients with less than 50% stenosis and no symptoms found that men were significantly more likely to have high-risk plaque features than women. Men had about four and a half times the odds of intraplaque hemorrhage and roughly five times the odds of advanced plaque types after adjusting for other variables.²⁴ A larger study looking at intraplaque hemorrhage across all stenosis levels found that men had dramatically higher odds at every age bracket studied, with the disparity most extreme in younger age groups.²⁵

This doesn’t mean women with mild stenosis can ignore it, but it does suggest that a man and a woman with identical ultrasound reports may have different plaque biology underneath. Clinical guidelines have not yet incorporated sex-specific plaque-composition criteria into management decisions, but the evidence is moving in that direction.

Why Plaque Forms Where It Does

The carotid artery splits into two branches just below the angle of the jaw, and this fork creates a natural zone of turbulent blood flow. Computational studies have shown that the bulb region near this bifurcation consistently experiences low shear stress along the vessel wall and high mechanical stress, a combination that promotes the earliest stages of plaque buildup. The exact geometry of the fork varies from person to person, and that individual anatomy influences how much of the artery wall sits in the “danger zone.”²⁶ ²⁷ This is why carotid plaque is not randomly distributed: it clusters at the bifurcation, and even modest plaque in that location sits in a mechanically active environment.

Artificial Intelligence and the Future of Plaque Assessment

One of the frustrations of current practice is that a standard ultrasound tells you how narrow the artery is but says little about what’s happening inside the plaque. Advanced MRI or CT-based techniques can reveal intraplaque hemorrhage, lipid-rich cores, and thin fibrous caps, but these scans aren’t routine. AI-driven image analysis is beginning to bridge the gap. A scoping review of AI applications in vulnerable plaque assessment highlighted a multicenter CT angiography study in which a model combining radiomics analysis of the tissue around the artery with clinical data achieved strong discriminative accuracy for identifying dangerous plaque features.²⁸ These tools are still largely in the research stage, but they hint at a future where a routine scan could flag not just the degree of narrowing but whether the plaque itself looks unstable, making it easier to identify the patients with “mild” stenosis who actually need closer watching.

It’s also worth noting that the standard measurement your report gives you, percent stenosis, is fundamentally a measure of blood-flow obstruction. Carotid intima-media thickness, another number sometimes measured on ultrasound, reflects generalized artery-wall thickening rather than focal plaque. These two measurements are biologically distinct and respond differently to treatment.²⁹ If you see both numbers on your report, understand that they are capturing different things: one is about the plaque itself, the other about the general health of the artery wall.